LISATA THERAPEUTICS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Lisata Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2024.
  • Lisata Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $246K, a 40% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $246K -$164K -40% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $290K -$159K -35.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $332K -$196K -37.1% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $371K -$217K -36.9% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $410K -$238K -36.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $449K -$259K -36.6% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $528K -$236K -30.9% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $588K +$227K +62.9% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $648K +$198K +44% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $708K +$175K +32.8% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $764K +$150K +24.4% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $361K -$333K -48% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $450K -$322K -41.7% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $533K -$314K -37.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $614K -$467K -43.2% Dec 31, 2020 10-K 2022-03-22
Q3 2020 $694K -$618K -47.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $772K -$630K -44.9% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $847K -$647K -43.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.08M +$772K +250% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $1.31M +$894K +214% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $1.4M +$959K +217% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.49M +$59.9K +4.18% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $309K -$1.41M -82.1% Dec 31, 2018 10-K 2020-03-05
Q3 2018 $418K -$999K -70.5% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $443K -$960K -68.4% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $1.43M +$779K +119% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $1.72M +$140K +8.84% Dec 31, 2017 10-K 2019-03-14
Q3 2017 $1.42M +$691K +95% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $1.4M +$590K +72.5% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $656K -$239K -26.7% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $1.58M +$605K +62% Dec 31, 2016 10-K 2018-03-22
Q3 2016 $727K -$483K -39.9% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $813K -$458K -36.1% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $895K -$431K -32.5% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $977K -$287K -22.7% Dec 31, 2015 10-K 2017-03-17
Q3 2015 $1.21M -$107K -8.16% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $1.27M -$188K -12.9% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $1.33M +$120K +9.99% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $1.26M +$112K +9.69% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $1.32M +$344K +35.3% Sep 30, 2014 10-Q 2014-10-30
Q2 2014 $1.46M +$469K +47.3% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $1.2M +$226K +23% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $1.15M +$204K +21.6% Dec 31, 2013 10-K 2015-03-02
Q3 2013 $973K +$40.8K +4.38% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $991K -$2.52M -71.8% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $979K -$5.19M -84.1% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $947K -$2.38M -71.5% Dec 31, 2012 10-K 2014-03-13
Q3 2012 $932K -$4.69M -83.4% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $3.51M +$79.9K +2.33% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $6.16M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 $3.33M +$529K +18.9% Dec 31, 2011 10-K 2013-03-11
Q3 2011 $5.63M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 $3.43M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 $2.8M Dec 31, 2010 8-K 2012-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.